Free Trial

Kiora Pharmaceuticals (KPRX) Earnings Date, Estimates & Call Transcripts

Kiora Pharmaceuticals logo
$3.00 -0.07 (-2.15%)
As of 05/23/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Kiora Pharmaceuticals Earnings Summary

Kiora Pharmaceuticals announced Q1 2025 earnings on May 9, 2025, reporting an EPS of -$0.52, which topped the consensus estimate of -$0.77 by $0.25. With a trailing EPS of -$2.90, Kiora Pharmaceuticals' earnings are expected to decrease next year, from $1.28 to ($2.76) per share.

Upcoming Q2
Earnings Date
Aug. 8Before Market OpensEstimated
Consensus EPS
(May. 9)
-$0.77
Actual EPS
(May. 9)
-$0.52 Beat By $0.25

Q1 2025 Earnings Resources

KPRX Upcoming Earnings

Kiora Pharmaceuticals' next earnings date is estimated for Friday, August 8, 2025, based on past reporting schedules.

Get Kiora Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kiora Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

KPRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KPRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Kiora Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251$0.67$0.67$0.67
Q2 20251-$0.66-$0.66-$0.66
Q3 20251-$0.67-$0.67-$0.67
Q4 20251-$0.67-$0.67-$0.67
FY 2025 4 -$1.33 -$1.33 -$1.33
Q1 20261-$0.61-$0.61-$0.61
Q2 20261-$0.59-$0.59-$0.59
Q3 20261-$0.58-$0.58-$0.58
Q4 20261-$0.58-$0.58-$0.58

Kiora Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/8/2025
(Estimated)
--------
5/9/2025Q1 2025-$0.77-$0.52+$0.25-$0.52$0.75M-
3/25/2025Q4 2024-$0.64-$1.04 -$0.40-$1.04$0.75M$0.75M
11/8/2024Q3 2024-$0.90-$0.81+$0.09-$0.81--
8/9/2024--$0.95-$0.53+$0.42-$0.53-$0.02M
5/10/2024Q1 2024$5.58$3.42 -$2.16$0.38$16.00M$16.00M
11/9/2023Q3 2023-$2.70-$8.01 -$5.31-$0.89--
8/8/2023Q2 2023-$4.59-$7.11 -$2.52-$0.79--

Kiora Pharmaceuticals Earnings - Frequently Asked Questions

Kiora Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 8th, 2025 based off last year's report dates. Learn more on KPRX's earnings history.

In the previous quarter, Kiora Pharmaceuticals (NASDAQ:KPRX) reported ($0.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.77) by $0.25. Learn more on analysts' earnings estimate vs. KPRX's actual earnings.

Kiora Pharmaceuticals's earnings report can be found in their filing with the SEC.
View SEC filing

Kiora Pharmaceuticals (NASDAQ:KPRX) has a recorded annual revenue of $16 million.

Kiora Pharmaceuticals (NASDAQ:KPRX) has a recorded net income of -$12.51 million. KPRX has generated -$2.90 earnings per share over the last four quarters.

Kiora Pharmaceuticals's earnings are expected to decrease from $1.28 per share to ($2.76) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:KPRX) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners